Hypertrophic Cardiomyopathy Rare in Elite Athletes


New research suggests that routine echocardiographic screening of elite athletes to detect hypertrophic cardiomyopathy (HCM) may not be warranted, as HCM is extremely rare in this population, according to an article published in the March 11 issue of the Journal of the American College of Cardiology.

Related Videos
Meghan Harrison, DO & Brittany Perry, DO
Steven Selbst, MD
Susan J. Kressly, MD, FAAP
Earls and Flower
Related Content
© 2023 MJH Life Sciences

All rights reserved.